Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves’ disease within one year-Reference-Cited by-同舟云学术

Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves’ disease within one year

Published:1989-10 Issue:9 Volume:12 Page:589-595
ISSN:0391-4097
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Talbot J. N.,Duron F.,Féron R.,Aubert P.,Milhaud G.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/BF03350008.pdf

Reference20 articles.

1. Solomon D.H., Beck J.C., van der Lann W.P., Astwood E.B. Prognosis of hyperthyroidism treated by antithyroid drugs. J. Am. Med. Ass. 152: 201, 1953.

2. Hershman J.M., Givens J.R., Cassidy C.E., Astwood E.B. Long term outcome of hyperthyroidism treated with antithyroid drugs. J. Clin. Endocrinol. Metab. 26: 803, 1966.

3. Dahlberg P.A., Karlsson F.A., Jansson R., Wide L. Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves’ disease as an indicator of remission. J. Clin. Endocrinol. Metab. 61: 1100, 1985.

4. Kawamura S., Kishino B., Tajima K., Mashita K., Tarui S. Serum thyroglobulin changes in patients with Graves’ disease treated with long term antithyroid drug therapy. J. Clin. Endocrinol. Metab. 56: 507, 1983.

5. Teng C.S., Yeung R.T.T. Changes in thyroid stimulating antibody in Graves’ disease treated with antithyroid drugs and its relationship to relapse. A prospective study. J. Clin. Endocrinol. Metab. 50: 144, 1980.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients;Endocrinology and Metabolism;2021-06-02

2. Serum TSH level as predictor of Graves’ disease recurrence following antithyroid drug withdrawal: A systematic review;PLOS ONE;2021-01-29

3. Predictors of long-term remission in patients with Graves’ disease: a single center experience;Endocrine;2013-02-11

4. Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission;Endocrine Journal;2011

5. Graves’ Disease;Endocrinology;2010